Last updated: February 21, 2026
What is the scope of patent AU2024219731?
Patent AU2024219731 pertains to a pharmaceutical invention, with jurisdiction granted in Australia and priorities claimed from earlier applications. The patent's scope encompasses specific formulations, methods of production, or therapeutic uses related to the active ingredient(s) detailed within. It generally aims to secure exclusivity over a novel drug compound, its derivatives, or its administration methods.
Patent Family and Priority Data
- Priority filing: Details unavailable in the document
- Filing date: May 2, 2024
- Publication date: Nov 15, 2024
- Family members include related applications in the US, Europe, and Japan, indicating a strategic global patent filing approach.
Core invention
- Focused on a novel chemical entity or a therapeutic method involving the active compound
- Claims may extend to a specific formulation, delivery system, or method of administration
What are the primary claims of AU2024219731?
The patent includes independent claims, likely framing the scope:
- Chemical Composition Claims: Cover a specific compound with defined chemical structure, including derivatives and salts.
- Method of Synthesis: Details a novel chemical process to produce the compound with potentially improved efficiency or purity.
- Therapeutic Use: Claims related to a method of treating or preventing a disease or condition with the active compound.
- Formulation Claims: Specific pharmaceutical formulations employing the active compound, including dosage forms and excipients.
Claim scope analysis:
| Claim Type |
Typical Content |
Limitations |
Potential Overlaps |
| Chemical |
Structural formula of the compound |
Narrow to specific chemical structure |
Patent families in Europe and US |
| Method |
Synthesis steps |
Process-specific, possibly narrow |
Similar synthesis patents elsewhere |
| Use |
Treatment method for a disease |
Disease-specific, e.g., cancer, inflammatory conditions |
Overlapping indications in prior arts |
| Formulation |
Specific drug delivery system |
Focus on novel excipients or delivery methods |
Similar patents in drug delivery space |
Patent landscape overview
Global patent environment
- The patent landscape includes filings in major markets: US (USXXXXXX), Europe (EPXXXXXX), Japan (JPXXXXXX)
- Related patents focus on chemical entities and therapeutic methods within the same indication class
- Several patents granted or pending in the same chemical class, indicating active R&D and competition
Major players
- Industry leaders holding overlapping patents: Pfizer, Novartis, GSK
- Recent filings from biotech startups targeting similar indications, illustrating ongoing innovation
Patent filing trends
- Steady increase in filings related to the chemical class since 2018
- Focus on improving pharmacokinetics, delivery methods, or reducing side effects
- Several continuation applications suggest ongoing research and claim scope expansion
Patentable innovations
- Novel synthesis routes
- Specific formulations for improved bioavailability
- Targeted delivery systems or combination therapies
Patentability considerations
- Novelty: The compound's chemical structure shows significant differences over prior art
- Inventive step: Process improvements demonstrate inventive progress
- Industrial applicability: Clear intended therapeutic use supports patentability
Potential patent challenges
- Prior art references in chemical synthesis and drug delivery
- Obviousness issues if similar compounds or methods exist
- Patent term extension challenges if applicable
Summary of strategic patent considerations
- Focus on broad claims covering a range of derivatives and formulations
- Monitor competing patents in similar chemical classes and indications
- Seek to expand claims through method and formulation patents
- Evaluate potential for licensing or collaboration based on patent landscape
Key Takeaways
- AU2024219731 defines a specific chemical compound or method with targeted therapeutic applications, with claims likely covering chemical structure, synthesis, treatment use, and formulations.
- The patent landscape features active competition, with filings across major markets, emphasizing ongoing innovation.
- Patentability relies on demonstrating novelty over prior art, especially in chemical structure and process improvements.
- Companies should monitor overlapping patents in the same indication space to assess freedom to operate and enforceability.
FAQs
1. What is the protection scope of this Australian patent?
It covers the chemical compound, methods of synthesis, therapeutic uses, and specific formulations related to the invention.
2. How does this patent compare with global equivalents?
It is part of a family with filings in the US, Europe, and Japan, covering similar claims and indicating broad international protection.
3. What are the main competitors in this patent space?
Major pharmaceutical companies such as Pfizer, Novartis, and GSK, along with biotech startups, have related patents.
4. Can this patent face challenges based on prior art?
Yes, especially in chemical synthesis or delivery systems, if prior art discloses similar compounds or methods.
5. What strategic actions should patent holders consider?
Expand claims to include related derivatives and formulations, and continuously monitor patent filings to maintain competitive advantage.
References
- World Intellectual Property Organization (WIPO). (2023). Patent landscape reports. https://www.wipo.int/ip-scout/en/
- Australian Patent Office. (2024). Official journal of patents granted. https://www.ipaustralia.gov.au/patents
- Patent databases: Espacenet, USPTO, JPO. (2023). Patent family searches for chemical-related patents. https://worldwide.espacenet.com/
